“Our very own medical director, Dr. Jeffry Gerson, is involved with eyecare beyond macular degeneration.” See the latest publication he has been working on:
ABSTRACT
Introduction:
This study assessed the effects of astaxanthin supplementation on chronic and acute digital eye strain in school-aged children (10–14years) and evaluated its safety. While previous studies focused on adults, this study examined astaxanthin’s effects on developing eyes.
Methods: A randomized, double-blind, placebo-controlled trial was conducted over 84 days involving 64 children engaged in≥4 h of screen time daily and experiencing mild to moderate computer vision syndrome (CVS) symptoms as indicated by a CVS-Questionnaire (CVS-Q) score≥8 and<19.
Participants received a daily 4-mg astaxanthin soft capsule for 84 days.
Primary outcomes were measured using CVS-Q, while secondary outcomes included visual fatigue Likert scale (VFLS), visual acuity, spherical equivalence, near point of accommodation, near exophoria, dry eye intensity, pupil size, stereopsis, blinking frequency, immunity, and safety variables.
Read more: https://rdcu.be/ebCQo
Source: Jeffry Gerson, OD, FAAO, Medical Director for the Macular Degeneration Association